How do ecthyma gangrenosum and erythema nodosum differ in presentation, etiology, and management?

Ecthyma Gangrenosum vs Erythema Nodosum: Key Distinctions

These are fundamentally different entities: ecthyma gangrenosum is a life-threatening infectious vasculitis requiring immediate broad-spectrum antibiotics, while erythema nodosum is a benign inflammatory panniculitis that typically resolves with supportive care.

Clinical Presentation

Ecthyma Gangrenosum

• Begins as painless erythematous papules that rapidly progress to painful necrotic ulcers with black eschars within 24 hours 1
• Lesions preferentially occur between the umbilicus and knees 1
• Can rapidly expand from 1 cm to >10 cm in <24 hours 1
• May be discrete or multiple lesions 1
• Represents cutaneous vasculitis with bacterial invasion of vessel walls visible on histology 1

Erythema Nodosum

• Presents as tender, erythematous subcutaneous nodules
• Typically located on the anterior shins bilaterally
• Does NOT ulcerate or necrose
• Evolves slowly over days to weeks, not hours
• Self-limited inflammatory process

Patient Population & Etiology

Ecthyma Gangrenosum

• Occurs almost exclusively in immunocompromised patients, particularly those with neutropenia 1, 2
• 79% of patients are immunocompromised 2
• Classically caused by Pseudomonas aeruginosa, but can be caused by other Pseudomonas species, Aeromonas, Serratia, S. aureus, Stenotrophomonas maltophilia, S. pyogenes, and fungi including Candida, Aspergillus, Mucor, and Fusarium 1
• Associated with bacteremia in most cases
• 38% develop sepsis 2
• Mortality rate approximately 34% 2

Erythema Nodosum

• Occurs in immunocompetent and immunocompromised patients
• Associated with inflammatory bowel disease, streptococcal infections, sarcoidosis, medications, pregnancy
• Not associated with bacteremia or sepsis
• Benign prognosis with no mortality

Management Approach

Ecthyma Gangrenosum - URGENT

Immediate hospitalization with empiric broad-spectrum antibiotics is mandatory 1:

1. Initial empiric therapy: Vancomycin PLUS antipseudomonal coverage (cefepime, carbapenem, or piperacillin-tazobactam) 1

   • Target gram-negative bacteria primarily due to high mortality rates 1

2. Diagnostic workup: Blood cultures, biopsy or aspiration of skin lesions for culture and histology 1

3. Duration: 7-14 days once pathogen identified and susceptibilities known 1

4. Surgical intervention: Consider for progressive necrotizing infection or after marrow recovery for abscess drainage 1

5. Adjust antibiotics based on culture results and susceptibilities 1

Erythema Nodosum - Supportive

• Treat underlying condition (e.g., IBD, streptococcal infection)
• NSAIDs for symptom relief
• Rest and leg elevation
• No antibiotics needed unless treating underlying bacterial trigger
• Self-resolves in weeks to months

Critical Pitfalls to Avoid

The most dangerous error is mistaking ecthyma gangrenosum for a benign process like erythema nodosum. Key distinguishing features:

• Necrosis and ulceration = ecthyma gangrenosum, NOT erythema nodosum
• Rapid progression (<24 hours) = ecthyma gangrenosum
• Immunocompromised/neutropenic patient with skin lesions = assume ecthyma gangrenosum until proven otherwise
• Any delay in antibiotic therapy for ecthyma gangrenosum significantly increases mortality risk

The evidence from 3, 4, 5 discusses pyoderma gangrenosum (not ecthyma gangrenosum) occurring with erythema nodosum in IBD patients—this is an entirely different clinical scenario and should not be confused with the comparison requested.